Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous immunoglobulin for Unverricht–Lundborg disease: single-patient trial
2017-002147-15Phase 3Completed
- Sponsor
- ASST Mantova
- Start
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of immune globulin in Unverricht-Lundborg disease (ULD), sponsored by ASST Mantova. Started Sep 2021; status: completed.
02
Drugs
immune globulin
03
Conditions
Unverricht-Lundborg disease (ULD)
Beyond the preview
Go deeper on 2017-002147-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002147-15.